Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BSX

Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink?

Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.

Barchart

The Sentiment Genome: BSX Stock Could Be Entering a High-Probability Setup

With the market signaling a hot deck, risk-tolerant speculators will want to keep close tabs on BSX stock over the next week.

Barchart

What to Expect From Boston Scientific’s Q1 2025 Earnings Report

Boston Scientific is expected to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit rise.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Boston Scientific Stock: Is BSX Outperforming the Healthcare Sector?

Boston Scientific has recently outpaced the broader healthcare sector, with analysts maintaining a highly bullish outlook on its future performance.

Barchart

3 Medical Device Stocks Seeing Surge in Demand

From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton, Dickinson and Company (BDX), and The Cooper Companies (COO), which could boost your portfolio. Keep reading….

StockNews.com

Is Wall Street Bullish or Bearish on Boston Scientific Stock?

Boston Scientific has notably outpaced the broader market over the past year. As a result, analysts are holding a highly optimistic outlook for its future prospects.

Barchart

Here's What to Expect From Boston Scientific's Next Earnings Report

Boston Scientific will release its fourth-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Boston Scientific Stock Outperforming the Dow?

Boston Scientific has outperformed the Dow recently, and analysts are strongly optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Boston Scientific Stock?

Boston Scientific has significantly outperformed the broader market over the past year, and analysts maintain a very bullish view on its outlook.

Barchart

Up 45% YTD, Should You Buy This Outperforming Healthcare Stock?

Boston Scientific shows impressive growth in Q3 results, garnering bullish analyst support despite clinical trial setbacks.

Barchart

Earnings Preview: What To Expect from Boston Scientific's Report

With Boston Scientific gearing up to release its third-quarter earnings later this month, analysts expect double-digit earnings growth.

Barchart

3 Healthcare Stocks Benefiting From Aging Populations

The healthcare industry is thriving, owing to the growing healthcare expenditure and aging population. Given the industry’s tailwinds, fundamentally sound healthcare stocks AbbVie (ABBV), Boston Scientific (BSX), and CVS Health (CVS) could be solid buys. Keep Reading….

StockNews.com

Is Boston Scientific Stock Outperforming the Nasdaq?

Boston Scientific has outperformed the Nasdaq Composite over the past year, and analysts remain bullish on the stock’s prospects.

Barchart

3 MedTech Stocks Innovating Healthcare

MedTech’s bright future is fueled by rapid tech advancements and increasing demand for medical devices, implants, and precision treatments, driven by an aging population and rising global disease rates. Given this backdrop, adding strong MedTech stocks like Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) to one’s portfolio could be…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Boston Scientific's Quarterly Earnings Preview: What You Need to Know

Boston Scientific is expected to report its second-quarter earnings results this month, and Wall Street analysts expect a single-digit profit growth.

Barchart

Is Boston Scientific Stock Outperforming the S&P 500?

Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects.

Barchart

Boston Scientific Stock: Is Wall Street Bullish or Bearish?

Boston Scientific has significantly outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects.

StockNews.com

Smith & Nephew (SNN) vs. Boston Scientific (BSX): Buy or Sell as These Medical Stocks Gear up for Quarterly Earnings?

The medical devices and equipment industry is primed to make significant strides toward growth this year, a surge propelled by increasing incidences of chronic diseases and the emphasis on early detection and treatment, coupled with leaps in technological development. Given this backdrop, let’s compare medical device stocks Boston Scientific (BSX)…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

4 Hyper-Growth Stocks That Could Soar

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on….

Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual return of 20.68%. Currently, Boston Scientific has a market capitalization of $54.31 billion.

Benzinga

Boston Scientific Buys Substantial Stake In Korean MedTech Player

Boston Scientific Corporation (NYSE:BSX) has agreed to purchase Synergy Innovation Co Ltd's majority stake (~64%) of M.I.Tech Co Ltd, a publicly-traded Korean manufacturer, and distributor of medical devices for endoscopic and urologic procedures. The deal is valued at KRW 14,500 per share, representing KRW 291.2 billion or approximately $230 million. M.I.Tech offers HANAROSTENT technology, a…

Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.09% on an annualized basis producing an average annual return of 20.41%. Currently, Boston Scientific has a market capitalization of $53.12 billion.

Benzinga

If You Invested $1000 In Boston Scientific 10 Years Ago, Here's How Much You Would Have Today

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.68% on an annualized basis producing an average annual return of 21.79%. Currently, Boston Scientific has a market capitalization of $58.91 billion.

Benzinga

Belo Sun Receives Interim Suspension Order Related To Volta Grande Project

Belo Sun Mining Corp. (TSX: BSX) (OTC: BSXGF)

Benzinga

Boston Scientific Jumps On Upbeat Q2, FY22 Guidance

Boston Scientific Corp (NYSE:BSX) generated net sales of $3.026 billion in Q1 FY22, beating the Wall Street estimate of $2.95 billion. Sales increased 10% Y/Y on a reported basis, 12.6% on an operational basis, and 9.7% on an organic basis, better than the management estimate of approximately 5% - 8%. The Company achieved…

1 2 3

People

Sristi Suman JayaswalThe

216 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

CVS Health Corporation

61 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.